|
|
|
|
|
||||||
|
||||||||||
ASRM 2007 Annual Meeting
Tuesday, October 16
Overview
Go back to Monday's Overview | Go to Wednesday's Overview
7:00 am-7:55 am
SPECIAL SESSION
Ballroom ABC
ADDITIVES TO ESTROGEN IN POSTMENOPAUSAL THERAPY: WHAT ARE THE ROLES OF
ANDROGENS AND PROGESTOGENS TODAY?
Supported by an educational grant from Solvay Pharmaceuticals, Inc.
7:00 a.m. – 7:55 a.m.
SPECIAL SESSION
Room: 201
Introduction: Significance of Hormonal Contraception
Vanessa Cullins, MD, MPH, MBA
Vice President for Medical Affairs, Planned Parenthood Federation of America
Contraception: Putting the Risks in Perspective
Carolyn Westhoff, MD
Professor of Obstetrics and Gynecology, Professor of Epidemiology and Population and Family Health;
Director, Division of Family Planning and Preventive Services, College of Physicians and Surgeons,
Columbia University in the City of New York
Supported by an Educational Grant from Ortho Women’s Health
Needs Assessment & Symposium Description:
In recent years, new delivery systems and new regimens for hormonal contraceptive agents have been developed to improve compliance and potential adverse events. New methods of hormonal contraception require careful assessment of efficacy and safety. The availability of new delivery systems and new dosing regimens has brought a resurgence of public scrutiny of hormonal contraception in general with attention focused on possible side effects. This presents the need to put the risks into perspective for the prescribing healthcare professional. All forms of contraception have risks and benefits. This program will provide specialists in reproductive medicine, family planning and gynecology with a broad overview of safety and efficacy profiles for all currently utilized delivery methods for hormonal contraceptives.
Learning Objectives:
At the conclusion of the Symposium, participants should be able to:
-
Compare the risks and benefits of various hormonal contraceptive methods.
-
Discuss the safety and efficacy profiles for all currently utilized delivery methods and dosing regimens for hormonal contraceptives.
PLENARY SESSION III
8:00 am-9:30 am
Room: Ballroom ABC
Chair: G. David Adamson, M.D.
8:00 am
WILLIAM C. ANDREWS WYETH ENDOWED LECTURE
Histocompatible Embryonic Stem Cells
George Q. Daley, M.D., Ph.D.
Introduced by: David L. Keefe, M.D.
Needs Assessment and Description:
Stem cells have been heralded as important tools for basic research and sources for cell replacement therapy in the context of degenerative disease. Human embryonic stem cells derive in most cases from embryos that are destined to be discarded after fertility treatments. It is imperative that practitioners of assisted reproduction be aware of the promise and limitations of human embryonic stem cell biology. Transplantation of stem cells is likely to face the same immunologic barriers as solid organ and marrow transplantation. This lecture will address the potential for medical applications of human embryonic stem cells, their derivation from excess IVF embryos, and the strategies for generating patientspecific stem cells that model disease and might be employed to overcome the immune barriers to cell transplantation. The presentation will review the strategies for producing histocompatible stem cells by parthenogenesis and somatic cell nuclear transfer, and will highlight the advantages and limitations of each approach for potential stem cell-based therapies.
Learning Objectives:
At the conclusion of the presentation, attendees should be able to:
-
Describe the derivation of customized embryonic stem cells lines by somatic cell nuclear transfer.
-
Explain the derivation of customized embryonic stem cells lines by parthenogenesis.
-
Explain the advantages and limitations of stem cell-based therapies.
8:45 am
EMD SERONO INC., ENDOWED LECTURE
Everything Conceivable: How Assisted Reproduction is Changing Men, Women and the World
Liza Mundy
Introduced by: Lee R. Collins, J.D.
Needs Assessment and Description:
Liza Mundy, a Washington Post staff writer and author of a major new book on ART, shows how reproductive technology
is driving profound social change. The social and political impact of ART is profound, and growing. Assisted reproduction is challenging established notions about human life and reproductive choice; creating unprecedented kinship patterns through the use of gamete donation and surrogacy; and altering family dynamics by increasing the prevalence of multiple births. ART professionals would benefit from an in-depth understanding of the social changes, and personal and political debates, their achievements are inspiring.
Learning Objectives:
At the conclusion of the presentation, attendees should be able to:
-
Summarize at least two profound social changes that are driving the use of ART.
-
Outline at least two ethical issues and decisions that may confront patients as they undergo fertility treatment.
-
Describe at least two ways in which ART is impacting the human family.
9:30 am-10:15 am
Refreshments in Exhibit Hall D
MORNING CONCURRENT SESSIONS, INCLUDING VIDEO PROGRAM AND SYMPOSIA
All rooms located in the Washington Convention Center.
GENERAL PROGRAM PRIZE PAPER CANDIDATES
Room: Ballroom ABC
10:15 am-12:00 pm
Moderators:
Anuja Dokras, M.D., Ph.D.
Elizabeth A. McGee, M.D.
10:15 am O-102
METHYLATION PATHWAY GENE POLYMORPHISMS ASSOCIATE WITH IN VITRO FERTILIZATION (IVF) OUTCOMES.
A. T. Dobson, A. Balendran, P. F. Rinaudo, M. I. Cedars, S. Shen, M. P. Rosen.
10:30 am O-103
COGNITIVE AND BEHAVIORAL PROFILES OF ICSI CHILDREN CONCEIVED FROM SURGICALLY
RETRIEVED SPERMATOZOA.
Q. V. Neri, M. Williams-Pitman, Z. Rosenwaks, J. Squires, G. D. Palermo. (In-Training Award for Research)
10:45 am O-104
MODULATION OF ANGIOGENESIS BY THE DOPAMINE AGONIST CABERGOLINE IN
EXPERIMENTALLY-INDUCEDPERITONEAL ENDOMETRIOTIC LESIONS.
E. Novella-Maestre, C. Simon, A. Pellicer.
11:00 am O-105
THIAZOLIDINEDIONES DECREASE VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) PRODUCTION BY HUMAN LUTEINIZED GRANULOSA CELLS IN VITRO.
D. K. Shah, K. M. J. Menon, S. K. Kavoussi, D. I. Lebovic. (Resident In-Training Award)
1:15 am O-106
ACUPUNCTURE LOWERS PREGNANCY RATES WHEN PERFORMED BEFORE AND AFTER EMBRYO TRANSFER.
L. B. Craig, A. R. Criniti, K. R. Hansen, L. A. Marshall, M. R. Soules.
11:30 am O-107
DECREASED IMPLANTATION RATE AFTER CERVICOVAGINAL EXPOSURE TO
LIPOPOLYSACCHARIDE, A POTENTIAL PATHWAY OF DECREASED UTERINE RECEPTIVITY BY
TOLL-LIKE RECEPTOR ACTIVATION.
R. A. Meter, M. Horton. (Reproductive Immunology SIG Prize Paper and In-Training Award for Research)
11:45 am O-108
A RANDOMIZED CONTROLLED TRIAL OF 503 COUPLES ASSIGNED TO CONVENTIONAL INFERTILITY TREATMENT OR AN ACCELERATED TRACK TO IVF: PRELIMINARY RESULTS OF
THE FAST TRACK AND STANDARD TREATMENT (FASTT) TRIAL.
R. H. Reindollar, M. M. Regan, P. J. Neumann, K. L. Thornton, M. M. Alper, M. B. Goldman.
CONTRACEPTION DAY KEYNOTE SPEAKER
10:15 am-11:00 am
The Cochrane Fertility Regulation Group: Synthesizing the Best Evidence About Family Planning
David A. Grimes, M.D.
Introduced by: Kurt T. Barnhart, M.D., M.S.C.E.
Room: 201
Needs Assessment and Description:
Finding the best available evidence to guide practice is important in family planning, as is true in other areas of medicine. This review will highlight clinical pearls that have emerged from Cochrane systematic reviews of fertility regulation methods. Clinicians need to be aware of current efforts to identify and synthesize all relevant randomized controlled trials in family planning, so that practice can be based on the best available evidence.
Learning Objectives:
At the conclusion of the presentation, attendees should be able to:
-
Describe the types of studies included in Cochrane systematic reviews.
-
Name at least two common methodological flaws in these published reports.
-
Explain at least one challenge to extrapolation of Cochrane review results.
-
Name at least one potential problem stemming from pharmaceutical industry sponsorship of contraceptive research.
VIDEO PROGRAM
10:15 am-Noon
Room: 207A
CONTRACEPTION DAY SYMPOSIUM
11:00 am-12:00 pm
The Politics Of Contraception
Room: 201
Moderator: Michael A. Thomas, M.D.
Presenters:
Vanessa Cullins, M.D., M.P.H., M.B.A., Vice President for Medical Affairs, Planned Parenthood Federation of America
Kirsten Moore, M.P.A., President, Reproductive Health Technologies Project
Wayne C. Shields, President and CEO, Association of Reproductive Health Professionals
Sean Tipton, M.A., Director of Public Affairs, American Society for Reproductive Medicine
Needs Assessment and Description:
The development of a contraceptive agent or device takes many years to get from concept to clinical research trials to market. Many of the barriers that affect this development include the political waters that have to be traversed in order to make a particular product acceptable to a pharmaceutical company, the Food and Drug Administration, and the woman or couple that will eventually utilize the product. This symposium will examine the politics that affect contraceptive development, approval, and marketing.
Learning Objectives:
At the conclusion of the symposium, the attendees should be able to:
-
Determine the political influences that play a role in determining whether a contraceptive comes to market.
-
Assess the interaction between the pharmaceutical industry and legislators.
-
Determine whether the lack of tort reform in the United States has an influence on contraceptive development.
SPECIAL NOON DEBATE
12:15 pm-1:15 pm
Preimplantation Genetic Screening Will Become an Integral Part of ART -- Yes or No?
Room: Hall A
Yes: Santiago Munne, Ph.D.
No: Marcus R. Hughes, M.D., Ph.D.
Moderators:
Marc A. Fritz, M.D.
David A. Grainger, M.D., M.P.H.
Needs Assessment and Description:
Whereas Preimplantation Genetic Diagnosis (PGD) has an established role in ART, the clinical
ultility of so-called Preimplantation Genetic Screening (PGS) to identify genetically "normal" embryos
is much less clear. Will PGS really improve outcomes with ART? The question is important to all
professionals engaged in ART. This debate will consider what the future of PGS in ART might be.
Learning Objectives:
At the conclusion of the presentation, attendees should be able to:
-
Discuss potential uses of PGS.
-
List the pitfalls of PGS.
12:15 pm-1:15 pm
ROUNDTABLE LUNCHEONS
Room: Hall E
12:15 pm-1:15 pm
INTERACTIVE SESSIONS
All rooms located in the Washington Convention Center.
12:15 pm-1:15 pm
Meet the Professor:* Choice in the New Reproductive Landscape
Liza Mundy
Room: 206
*A ticket is required for this activity. Lunch included.
PLENARY SESSION IV
1:30 pm-2:15 pm
Room: Ballroom ABC
Chair: William R. Keye, Jr., M.D.
1:30 pm
SRS/ETHICON ENDO-SURGERY, INC., ENDOWED LECTURE
Microsurgery for Male Infertility: Life at the Cutting Edge
Marc Goldstein, M.D.
Introduced by: Peter N. Schlegel, M.D., President, SRS
Needs Assessment and Description:
Microsurgery has dramatically improved the treatment of male infertility, necessitating special training that will be described. It will be shown how microsurgical treatment of obstructive and non-obstructive azoospermia allow a majority of couples to become candidates for ART.
Microsurgery is a critical component of surgical therapy for infertility. Based on examination of CME feedback responses, input of SRS members, and the SRS Board, a substantial need exists to 1) standardize training in, and assessment of, microsurgical skills, and 2) increase awareness of the advances in microsurgery that have dramatically improved outcomes for men with obstructive and non-obstructive azoospermia, as well as varicocele.
Learning Objectives:
At the conclusion of the presentation, attendees should be able to:
-
Describe the graduated approach to microsurgical training and assessment of skills.
-
Specify the advantages of microsurgical technique for male infertility procedures.
-
Estimate expected outcomes for microsurgical treatment of obstructive and non-obstructive azoospermia, as well as varicocele.
2:15 pm-3:00 pm
Refreshments in Exhibit Hall D
AFTERNOON CONCURRENT SESSIONS
All rooms located in the Washington Convention Center.
THE SOCIETY FOR ASSISTED REPRODUCTIVE TECHNOLOGY ABSTRACTS
Room: 147AB
3:00 pm-5:00 pm
Moderators:
David A. Grainger, M.D., M.P.H.
Mark D. Hornstein, M.D.
3:00 pm O-109
ASSISTED REPRODUCTION WITH SPERM FROM HIV-INFECTED MEN.
A. A. Kiessling, B. D. Desmarais, H.- Z. Yin, M. C. Kearnan. (SART Prize Paper)
3:15 pm O-110
m3RNA TRANSCRIPT PROFILING OF HUMAN OOCYTES AT DIFFERENT MATURATIONAL STAGES AND AFTER IN VITRO MATURATION.
D. Wells, P. Patrizio.
3:30 pm O-111
AMONG WOMEN UNDERGOING EMBRYO TRANSFER, IS THE PROBABILITY OF PREGNANCY AND LIVE BIRTH IMPROVED WITH ULTRASOUND-GUIDANCE THAN WITH CLINICAL TOUCH
ALONE? META-ANALYSIS OF PROSPECTIVE RANDOMIZED TRIALS.
A. M. Abou-Setta, H. G. Al-Inany.
3:45 pm O-112
CLINICAL EVALUATION OF THE EFFICIENCY OF OOCYTE DONATION PROGRAM USING EGG
CRYO-BANKING.
Z. P. Nagy, C.-C. Chang, D. Shapiro, C. Elsner, D. Mitchell-Leef, H. Kort.
4:00 pm O-113
ADJUVANT CELL CULTURE IS REQUIRED FOR DERIVING EMBRYONIC STEM CELLS FROM INDIVIDUALLY BIOPSIED INNER CELL MASS CELLS.
T. Takeuchi, Q. V. Neri, A. Seriola, M. Cheng, G. D. Palermo.
4:15 pm O-114
A RANDOMIZED, PROSPECTIVE, ASSESSOR-BLIND, PARALLEL GROUPS, COMPARING GNRHA VS. RHCG AS A TRIGGER FINAL OOCYTE MATURATION IN GNRH ANTAGONIST
IVF/ICSI CYCLES.
M. A. B. Melo, C. E. Busso, P. Alama, M. Meseguer, N. Garrido, J. Remohi.
4:30 pm O-115
GENE EXPRESSION ANALYSIS OF THE ENDOMETRIUM REVEALS THAT CONTROLLED OVARIAN STIMULATION INDUCES A GENOMIC DELAY WITH POTENTIAL CLINICAL
IMPLICATIONS.
J. A. Horcajadas, P. Minguez, J. Dopazo, F. J. Esteban, A. Pellicer, C. Simon.
4:45 pm O-116
FREEZING OF CLEAVAGE STAGE HUMAN EMBRYOS NEGATIVELY IMPACTS METABOLISM COMPARED TO CRYOPRESERVATION
BY VITRIFICATION.
B. Balaban, B. Urman, A. Isiklar, M. G. Larman, B. Hamilton, D. K. Gardner.
SOCIETY OF REPRODUCTIVE SURGEONS ABSTRACTS
Room: 145AB
3:00 pm-5:00 pm
Moderators:
Peter N. Schlegel, M.D.
Tommaso Falcone, M.D.
3:00 pm O-117
AN ANIMAL MODEL OF UTERINE AUTO AND ALLO-TRANSPLANTATION WITH THE ACHIEVEMENT OF PREGNANCY.
E. R. Ramirez, H. A. Ramirez, D. K. Ramirez, V. T. Pillari, D. Baldwin, J. A. Ramirez.
3:15 pm O-118
ISCHEMIC CHANGES IN THE PRIMATE UTERUS AFTER ALLOGRAFT TRANSPLANTATION.
J. Stega, S. Schlatt, D. Schron, W. Miller, A. Nair, G. Del Priore.
3:30 pm O-119
COMPARISON OF OVARIAN CORTICAL TISSUE GRAFTING VERSUS INTACT WHOLE OVARY MICROVASCULAR HOMOTRANSPLANTATION AND ALLOTRANSPLANTATION FOR PATIENTS
WITH PREMATURE OVARIAN FAILURE.
S. J. Silber, J. A. Pineda, M. DeRosa, K. S. Gorman, P. Patrizio, R. G. Gosden.
3:45 pm O-120
RESTORATION OF LONG-TERM OVARIAN FUNCTION AFTER HETEROTOPIC AUTOTRANSPLANTATION OF CRYOBANKED HUMAN OVARIAN TISSUE: SIX YEAR CLINICAL
EXPERIENCE.
S. S. Kim, W. S. Lee, M. K. Chung, H. C. Lee, H. H. Lee, D. Hill. (SRS Prize Paper)
SRS Debate
4:00 pm-5:00 pm
Surgery vs. Uterine Artery Embolization for Fibroids in the Treatment of Symptomatic Women and Women Desiring Fertility
Room: 145AB
Chair: Ana A. Murphy, M.D.
Presenters:
Samantha M. Pfeifer, M.D.
James B. Spies, M.D.
SREI FELLOWS RESEARCH ABSTRACTS
Room: 152AB
3:00 pm-4:00 pm
Moderators:
Michael P. Diamond, M.D.
Christos Coutifaris, M.D., Ph.D.
3:00 pm O-121
LEPTIN INCREASES VEGF AND VEGF-RECEPTOR EXPRESSION IN HUMAN UTERINE LEIOMYOMA CELLS IN VITRO.
E. E. Marsh, Z. Lin, P. Yin, E. Confino, M. P. Milad, S. E. Bulun.
Discussant: Ghassan Saed, Ph.D.
3:20 pm O-122
EVIDENCE FOR A MULLERIAN INHIBITING SUBSTANCE (MIS) AUTOCRINE/PARACRINE SYSTEM IN ADULT HUMAN ENDOMETRIUM.
J. G. Wang, C. L. Dicken, J. W. Lustbader, D. V. Tortoriello.
Discussant: Elizabeth E. Puscheck, M.D.
3:40 pm O-123
ASSESSMENT OF ANTI-MULLERIAN HORMONE (AMH) LEVELS IN PREPUBERTAL CHILDREN UNDERGOING GONADOTOXIC
CHEMOTHERAPY: A POTENTIAL GONADAL RESERVE MARKER.
M. A. Bedaiwy, R. Z. Mahfouz, H. Kubaney, G. Plautz, R. S. Peterson, T. Falcone.
Discussant: Esther Eisenberg, M.D.
REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY ABSTRACTS
Room: 152AB
4:00 pm-5:00 pm
Moderators:
Tony G. Zreik, M.D.
Eric J. Bieber, M.D.
4:00 pm O-124
HUMAN OOCYTE CRYOPRESERVATION: PRELIMINARY RESULTS OF SURVIVAL, FERTILIZATION AND CLEAVAGE RATE OF FROZEN OOCYTE USING A NEW MODIFIED SLOW-FREEZE PROTOCOL.
D. G. Diaz, M. C. Rodriguez-Karl, J. E. Moody, A.-T. H. La.
4:15 pm O-125
SPASTIN IS A NOVEL COFACTOR OF HOXA10 IN THE REGULATION OF PERI-IMPLANTATION
ENDOMETRIAL GENE EXPRESSION.
G. S. Daftary, A. M. Tetrault, H. S. Taylor.
4:30 pm O-126
EVIDENCE OF MODULATION OF FOLLICLE RESPONSIVENESS TO FSH BY ANTI-MÜLLERIAN
HORMONE IN NORMO-OVULATING WOMEN.
J. Scheffer, M. Grynberg, J. Taieb, A. Bussab, R. Frydman, R. Fanchin.
4:45 pm O-127
PHYSIOLOGIC TRANSDERMAL ESTRADIOL REPLACEMENT THERAPY RESTORES FEMORAL NECK BONE DENSITY IN WOMEN WITH SPONTANEOUS 46,XX PRIMARY OVARIAN
INSUFFICIENCY: 3 YEAR RANDOMIZED CONTROLLED CLINICAL TRIAL.
V. B. Popat, S. Kalantaridou, J. C. Reynolds, K. Calis, J. Troendle, L. M. Nelson.
SMRU TRAVELING SCHOLARS ABSTRACTS
Room: 209ABC
3:00 pm-5:00 pm
Moderators:
Susan H. Benoff, Ph.D.
Moshe Wald, M.D.
3:00 pm O-128
SPERM DNA DAMAGE: IS ALTERED CARBOHYDRATE METABOLISM TO BLAME?
H. W. Bakos, J. G. Thompson, M. Lane.
3:15 pm O-129
A NOVEL FORM OF THE "WHITAKER TEST" FOR EJACULATORY DUCT OBSTRUCTION.
M. L. Eisenberg, K. Shinohara, M. M. Garcia, P. J. Turek. (SMRU Prize Paper and In-Training Award for Research)
3:30 pm O-130
RELATIONSHIP OF PUBERTAL GYNECOMASTIA WITH VARICOCELE AND VARIOUS PARAMETERS OF GROWTH: A SEVEN YEAR PROSPECTIVE STUDY.
F. Deepinder, P. Kumanov, R. Robeva, A. Tomova, I. Puri, A. Agarwal.
3:45 pm O-131
PROLIFERATION AND DIFFERENTIATION OF MALE GERM-LINE STEM CELLS FROM TESTES
OF NON-OBSTRUCTIVE AZOOSPERMIA USING SEQUENTIAL CULTURE SYSTEMS.
J. J. Lim, D. R. Lee, H. J. Kim, S. H. Song, T. K. Yoon, K. S. Kim.
4:00 pm O-132
COMBINED EFFECTS OF THE EXPERIMENTAL LEFT VARICOCELE AND LEAD OR NICOTINE ON THE RAT TESTIS.
B. R. Emery, Y. Sun, D. T. Carrell.
4:15 pm O-133
VARICOCELECTOMY FOR INFERTILE COUPLES WITH ADVANCED PATERNAL AGE.
A. Grunbaum, J. Boman, A. Zini.
4:30 pm-5:30 pm
MINI SYMPOSIUM
Ethical Dilemmas in Male Infertility
Presenter: Anthony J. Thomas, Jr., M.D.
CONTRACEPTION SPECIAL INTEREST GROUP ABSTRACTS
Room: 201
3:00 pm-5:00 pm
Moderators:
Susan A. Ballagh, M.D.
Steven J. Sondheimer, M.D.
3:00 pm O-134
DEVELOPMENT OF AN RNAi-BASED CONTRACEPTIVE.
Z. Williams, E. Litscher, P. M. Wassarman.
3:15 pm O-135
IMPACT OF OBESITY ON ORAL CONTRACEPTIVE PHARMACOKINETICS AND HYPOTHALAMICPITUITARY-OVARIAN ACTIVITY: A MECHANISM FOR CONTRACEPTIVE
FAILURE?
A. B. Edelman, N. E. Carlson, R. L. Stouffer, J. L. Cameron, F. Z. Stanczyk, J. T. Jensen.
3:30 pm O-136
SEXUAL FUNCTION IN FIRST-TIME NUVARING® AND ORTHOEVRA® USERS.
C. R. Gracia, H. Lin, S. Charlesworth, C. Schreiber, K. T. Barnhart, M. Creinin.
3:45 pm O-137
3:45 pm O-137
EFFECT OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) WITHDRAWAL ON APOPTOSIS IN AN IMMORTALIZED HUMAN ENDOMETRIAL ENDOTHELIAL CELL (HEEC) LINE.
T. D. Deutch, S. Zhao, C. Chainarong, T. D. Kimble, D. F. Archer.
4:00 pm O-138
EFFECT OF TRANSDERMAL AND TRANSVAGINAL ADMINISTRATION OF CONTRACEPTIVE STEROIDS ON MARKERS OF THROMBOSIS.
J. T. Jensen, A. Burke, K. T. Barnhardt, M. Messerle-Forbes, C. Tillotson, D. Peters.
4:15 pm O-139
EMERGENCY CONTRACEPTION POTENTIAL OF LEPTIN SIGNALING INHIBITION IN A MOUSE
MODEL.
R. R. Gonzalez, S. Cherfils, D. Ngugi, P. Cipriani, M. Olatinwo, B. R. Rueda.
4:30 pm O-140
THE SEARCH FOR A CANDIDATE VAGINAL GEL: AN IMAGING TRIAL OF THE DISTRIBUTION OF
FOUR TOPICAL GEL FORMULATIONS IN THE HUMAN VAGINA.
J. L. Kulp, M. Rosen, D. Shera, A. Hummel, K. T. Barnhart.
4:45 pm O-141
GRANULOSA CELLS ARE NOT A SOURCE OF INSULIN-LIKE FACTOR 3 (INSL3) IN FOLLICULAR
FLUID DURING THE PERIOVULATORY INTERVAL IN RHESUS MACAQUES.
J. T. Jensen, J. Hennebold, F. Xu, R. Yeoman, M. J. Murphy, X. Wu.
PEDIATRIC AND ADOLESCENT GYNECOLOGY SPECIAL INTEREST GROUP ABSTRACTS
Room: 143C
3:00 pm-4:00 pm
Moderators:
David M. Lee, M.D.
Yolanda R. Smith, M.D.
3:00 pm O-142
THROMBOCYTOSIS ASSOCIATED WITH MALIGNANT OVARIAN LESIONS WITHIN A PEDIATRIC
AND ADOLESCENT POPULATION.
L. B. Haddad, M. R. Laufer.
3:15 pm O-143
LARGE BENIGN OVARIAN CYSTS IN ADOLESCENTS: SURGICAL MANAGEMENT OPTIONS AND
FOLLOW UP.
J. Reddy, M. R. Laufer.
3:30 pm O-144
DIAGNOSIS AND MANAGEMENT OF DIDELPHIC UTERUS, OBSTRUCTED HEMIVAGINA AND IPSILATERAL RENAL AGENESIS (HERLYN-WERNER-WUNDERLICH SYNDROME): THE
WASHINGTON UNIVERSITY EXPERIENCE.
T. Nguyen, L. Lawrence, V. Ratts, R. Odem, C. Siegel, D. Merritt.
3:45 pm O-145
A RARE CASE OF A DOUBLE RESORPTION DEFECT.
M. B. Stanek, E. Quint, H. Hussain, Y. R. Smith.
SEXUALITY SPECIAL INTEREST GROUP ABSTRACTS
Room: 143C
4:00 pm-5:00 pm
Moderators:
Sheryl A. Kingsberg, Ph.D.
John P. Mulhall, M.D.
4:00 pm O-146
POTENCY STATUS AFTER RADICAL PROSTATECTOMY WITH AND WITHOUT ORAL THERAPY AND ERECTAIDS.
G. Pahlajani, R. Raina, A. Agarwal, C. D. Zippe.
4:15 pm O-147
HYPOACTIVE SEXUAL DESIRE DISORDER IN POSTMENOPAUSAL WOMEN: IS THERE A RELATION WITH HORMONE REPLACEMENT
THERAPY AND SEX STEROID HORMONAL LEVELS?
Z. R. Hubayter, L. Mains, M. M. Magnus, G. Richard-Davis.
4:30 pm O-148
RESIDENTS AND FEMALE SEXUAL DYSFUNCTION: WHAT DO THEY KNOW?
T. L. Woodard, N. Hallak, R. T. Segraves.
4:45 pm O-149
A RIGIDITY QUESTION INCREASES THE SENSITIVITY OF THE SEXUAL HEALTH INVENTORY OF
MEN QUESTIONNAIRE FOR COMPARISON OF PHOSPHODIESTERASE-5 INHIBITOR THERAPIES.
G. Pahlajani, R. Raina, A. Agarwal, C. D. Zippe.
REPRODUCTIVE IMMUNOLOGY SPECIAL INTEREST GROUP ABSTRACTS
Room: 159AB
3:00 pm-5:00 pm
Moderators:
Danny J. Schust, M.D.
Deborah J. Anderson, Ph.D.
3:00 pm O-150
ENDOMETRIAL VASCULARITY BY THREE-DIMENSIONAL POWER DOPPLER ULTRASOUND AND CYTOKINES: A COMPLEMENTARY APPROACH TO ASSESS UTERINE RECEPTIVITY.
N. Ledee, R. Lombroso, V. Serazin, S. Dubanchet, Y. Ville, G. Chaouat.
3:15 pm O-151
VASCULAR ENDOTHELIAL GROWTH FACTOR GENE POLYMORPHISMS AND RECURRENT IMPLANTATION FAILURE.
C. B. Coulam, R. S. Jeyendran.
3:30 pm O-152
DO CYTOKINE LEVELS IN THE SUPERNATANT FROM CONDITIONED MEDIA (CM) OF EMBRYOS GROWN IN AUTOLOGOUS
ENDOMETRIAL COCULTURE (AECC) CORRELATE WITH PREGNANCY OUTCOMES AFTER IN VITRO FERTILIZATION (IVF)?
K. A. Bendikson, J. Park, Z. Rosenwaks, S. D. Spandorfer.
3:45 pm O-153
EFFECTS OF SERUM CYTOKINES (INTERLEUKIN-6, ITERLEUKIN-18) IN WOMEN UNDERGOING
IN VITRO FERTILIZATION (IVF), DURING THE LUTEAL PHASE, ON PREGNANCY OUTCOME.
P. Drakakis, D. Loutradis, E. Vomvolaki, K. Stefanidis, S. Milingos, A. Antsaklis.
4:00 pm O-154
STUDY ON THE CORRELATION BETWEEN LOW-GRADE CHRONIC INFLAMMATION AND PATHOGENESIS OF POLYCYSTIC OVARY
SYNDROME.
Y. Yang, J. Qiao, M. Li.
4:15 pm O-155
DECREASED IL-2 PRODUCTION FROM T CELLS IN A LOW ESTROGEN ENVIRONMENT.
L. T. Ku, C. Gercel-Taylor, S. T. Nakajima, D. D. Taylor.
4:30 pm O-156
CONSTRUCTION OF ROC CURVES TO ASSESS THE VALUE OF ANTISPERM ANTIBODIES IN DISTINGUISHING OBSTRUCTIVE FROM
NONOBSTRUCTIVE AZOOSPERMIA.
R. Lee, B. W. Ullery, J. Ehrlich, R. A. Razzano, M. A. Callahan, M. Goldstein.
4:45 pm O-157
NITRIC OXIDE SYNTHASE ISOFORMS ARE DIFFERENTIALLY EXPRESSED IN FIBROBLASTS
ISOLATED FROM HUMAN NORMAL PERITONEUM AND ADHESION TISSUES.
Z. L. Jiang, N. M. Fletcher, M. P. Diamond, H. M. Abu-Soud, G. M. Saed.
ENDOMETRIOSIS ABSTRACTS
Room: 146C
3:00 pm-5:00 pm
Moderators:
Robert N. Taylor, M.D.
Kathy L. Sharpe-Timms, Ph.D.
3:00 pm O-158
PROGESTERONE RESISTANCE IN ENDOMETRIOSIS: EXAMINATION OF L-SELECTIN LIGAND
IN EUTOPIC AND ECTOPIC ENDOMETRIUM USING IN VIVO AND IN VITRO MODELS.
W. A. Palomino, C. E. Likes, B. Mo, D. A. Forstein, P. B. Miller, B. A. Lessey.
3:15 pm O-159
ERß REGULATES ERa EXPRESSION AND RESPONSE TO ESTRADIOL VIA SPECIFIC PROMOTERS IN ENDOMETRIUM AND
ENDOMETRIOSIS.
E. Trukhacheva, Z. Lin, M. Milad, E. Confino, S. E. Bulun.
3:30 pm O-160
EFFECTS OF A NOVEL SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM) ON CELL PROLIFERATION AND GROWTH IN A
MACAQUE AUTOGRAFT MODEL FOR ENDOMETRIOSIS.
R. Carroll, U. Kaufmann-Reiche, A. Schmidt, U. Fuhrmann, K. H. Fritzemeier, O. D. Slayden.
3:45 pm O-161
IMATINIB DECREASES ENDOMETRIAL STROMAL CELL TRANSMESOTHELIAL MIGRATION AND
PROLIFERATION IN THE EXTRACELLULAR MATRIX OF MODELED PERITONEUM.
J. S. Griffith, P. A. Binkley, N. B. Kirma, R. S. Schenken, R. R. Tekmal, C. A. Witz.
4:00 pm O-162
STEM CELL ANTIGENS IN ECTOPIC EPITHELIAL CELLS OF ENDOMETRIOTIC LESIONS: IS
ENDOMETRIOSIS A DISEASE ORIGINATED FROM STEM CELLS?
M. Sbracia, F. Scarpellini, D. Marconi, E. Zupi, F. Klinger, D. Arduini.
4:15 pm O-163
DEVELOPMENTAL DIOXIN EXPOSURE IN MICE ALTERS UTERINE DNA METHYLATION PATTERNS AND PROTEIN EXPRESSION IN ADULT ANIMALS AND LEADS TO AN
ENDOMETRIOSIS-LIKE PHENOTYPE.
K. L. Bruner-Tran, G. R. Yeaman, E. Eisenberg, K. G. Osteen.
4:30 pm O-164
PPAR-GAMMA LIGAND ACTIVATION DECREASES AROMATASE EXPRESSION IN ENDOMETRIAL STROMAL CELLS.
S. K. Kavoussi, K. M. J. Menon, H. Peegel, G. M. Christman, S.-W. Guo, D. I. Lebovic.
4:45 pm O-165
MATRIX METALLOPROTEINASES IN PATIENT URINE AS NON-INVASIVE SURROGATE MARKERS FOR ENDOMETRIOSIS.
C. M. Becker, A. Exarhopoulos, G. Louis, A. D. Ebert, D. Zurakowski, M. A. Moses.
OUTCOME PREDICTORS-CLINICAL:ART ABSTRACTS
Room: 150AB
3:00 pm-5:00 pm
Moderators:
Judy E. Stern, Ph.D.
Owen K. Davis, M.D.
3:00 pm O-166
INTRAUTERINE GROWTH RETARDATION IN DONOR OOCYTE RECIPIENTS COMPARED TO IVF
PREGNANCIES WITH THEIR OWN OOCYTES.
J. Llacer, L. Luque, J. M. Gomez Santana, J. M. Lozano, J. Ten, R. Bernabeu.
3:15 pm O-167
OPTIMIZING THE NUMBER OF BLASTOCYST STAGE EMBRYOS TO TRANSFER IN WOMEN 38 AND OLDER: A SART DATABASE STUDY.
J. E. Stern, M. B. Goldman, H. Hatasaka, T. A. MacKenzie, C Racowsky, E. S. Surrey.
3:30 pm O-168
THE LEADING FOLLICLE DIAMETER ON GNRH ANTAGONIST START DAY MAY PREDICT THE
OUTCOMES OF IVF-ET CYCLES.
S.-Y. Ku, H.-C. Liu, W. Wang, Z. He, Y. Tang, Z. Rosenwaks.
3:45 pm O-169
PCOS, OBESITY, AND IVF.
E. S. Jungheim, K. H. Moley, R. R. Odem, A. S. Chang, S. E. Lanzendorf, V. S. Ratts.
4:00 pm O-170
SINGLE BLASTOCYST TRANSFER (SBT) APPLIED IN AN OOCYTE DONATION PROGRAM: ONE
PHYSICIAN'S THREE YEAR EXPERIENCE.
S. J. Chantilis, D. Ward, T. Davidson, L. Blankenship, M. Meintjes.
4:15 pm O-171
RELATIONSHIP OF ENZYMATIC ANTIOXIDANTS IN THE FOLLICULAR FLUID AND SEMEN OF
INFERTILE COUPLES WITH ASSISTED REPRODUCTION OUTCOMES.
E. B. Pasqualotto, R. Sharma, M. Salvador, E. Borges, A. Agarwal, F. F. Pasqualotto.
4:30 pm O-172
DOES BLASTOMERE BIOPSY IN PREIMPLANTATION GENETIC DIAGNOSIS (PGD) AFFECT EARLY SERUM hCG LEVEL?
Y. J. Cho, J. H. Jun, J. Y. Kim, I. O. Song, M. K. Koong, I. S. Kang.
4:45 pm O-173
SPONTANEOUS ABORTION IN DONOR OOCYTE RECIPIENTS: THE RISK ASSOCIATED WITH EXTREMES OF BODY MASS.
C. M. Arnett, J. Q. Huang, Z. Rosenwaks, S. D. Spandorfer.
REPRODUCTIVE BIOLOGY: HUMAN STUDIES ABSTRACTS
Room: 206
3:00 pm-5:00 pm
Moderators:
Amy E.T. Sparks, Ph.D.
Marlane J. Angle, Ph.D.
3:00 pm O-174
ETIOLOGY OF INFERTILITY AFFECTS SUBSEQUENT BLASTOCYST TRANSCRIPTOME.
M. G. Katz-Jaffe, B. R. McCallie, J. A. Filipovits, W. B. Schoolcraft, D. K. Gardner.
3:15 pm O-175
HEMATOPOIESIS IN THE FIRST TRIMESTER HUMAN PLACENTA: A MODEL FOR UNDERSTANDING HUMAN STEM CELL DEVELOPMENT.
A. Huang, B. Van Handel, S. Prashad, E. Hamalainen, M. Magnusson, H. Mikkola.
3:30 pm O-176
DIFFERENTIAL CUMULUS CELL GENE EXPRESSION IN YOUNG WOMEN WITH DIMINISHED OVARIAN RESERVE.
K. Greenseid, S. Jindal, M. Nihsen, J. M. Hurwitz, N. S. Santoro, L. Pal.
3:45 pm O-177
NOVEL STABLE GLUTAMINE DERIVATIVE ACHIEVED DRAMATIC IMPROVEMENT OF DEVELOPMENTAL COMPETENCE OF HUMAN EMBRYOS.
S. Hashimoto, T. Nishihara, Y. Murata, H. Oku, A. Fukuda, Y. Morimoto.
4:00 pm O-178
METABOLOMIC SCREENING THROUGH LONG WAVE LENGTH NEAR INFRARED BIOSPECTROSCOPY OF SPENT EMBRYO CULTURE MEDIA PREDICTS HUMAN EMBRYONIC
REPRODUCTIVE POTENTIAL - A PROSPECTIVE BLINDED STUDY.
R. T. Scott, Jr, K. Miller, J. L. Frattarelli, D. Burns.
4:15 pm O-179
AN INCREASED INCIDENCE OF MLH1 FOCI AT LOCATIONS PROXIMAL TO THE CENTROMERES
OF PACHYTENE SPERMATOCYTES IN INFERTILE MEN WHEN COMPARED TO CONTROLS.
M. L. Sanderson, J. B. M. Mullen, S. I. Moskovtsev, D. T. Carrell.
4:30 pm O-180
A BROAD EPIGENETIC DEFECT OF ABNORMAL HUMAN SPERM IS SUGGESTED BY ELEVATED METHYLATION OF NUMEROUS DNA SEQUENCES IN SPERM OF LOW
CONCENTRATION, POOR MORPHOLOGY AND POOR MOTILITY.
V. K. Cortessis, S. Houshdaran, K. Siegmund, A. S. Yang, P. W. Laird, R. Z. Sokol.
4:45 pm O-181
THE IMPACT OF SINGLE INTRAMURAL MYOMAS ON ENDOMETRIAL RECEPTIVITY: A HISTOLOGICAL AND GENOMIC ANALYSIS.
M. A. Higon, J. A. Horcajadas, J. A. Martinez-Conejero, C. Simon, A. Pellicer.
REPRODUCTIVE BIOLOGY: ANIMAL AND EXPERIMENTAL MODELS ABSTRACTS
Room: 154AB
3:00 pm-5:00 pm
Moderators:
Hugh C. Hensleigh, Ph.D.
David H. McCulloh, Ph.D.
3:00 pm O-182
IN VIVO INDUCTION OF OVARYLIKE STRUCTURES FROM EMBRYONIC STEM CELLS.
W. Wang, H.-C. Liu, Z. He, Z. Rosenwaks.
3:15 pm O-183 WITHDRAWN
3:30 pm O-184
EARLY EXPRESSION OF LEPTIN RECEPTORS IN THE DIENCEPHALON OF THE DEVELOPING
CHICKEN EMBRYO.
C. L. Casey, S. L. White, C. J. Forehand.
3:45 pm O-185
MARKED CHANGES IN THE CIRCULATING LEVELS AND RATIOS OF ANGIOPOIETINS DURING
PREGNANCY, COMPARED TO NATURAL MENSTRUAL CYCLES AND CONTROLLED OVARIAN STIMULATION.
A. K. Hurliman, R. L. Stouffer, P. E. Patton, L. Speroff, T. A. Molskness.
4:00 pm O-186
NOVEL MATERNAL EFFECT GENE ESSENTIAL FOR PROGRESSION BEYOND THE EARLY CLEAVAGE STAGE OF MOUSE EMBRYOGENESIS.
L. Li, B. Baibakov, L. Gauthier, J. Dean.
4:15 pm O-187
SYSTEMATIC IDENTIFICATION OF PROTEASE GENES THAT ARE DIFFERENTIALLY EXPRESSED IN THE PRIMATE FOLLICLE DURING
THE PERIOVULATORY INTERVAL.
J. D. Hennebold, M. J. Murphy, F. Xu, T. Wintermantel, B. Lindenthal, R. L. Stouffer.
4:30 pm O-188
EFFECTS OF SB-431542 ON GROWTH AND GENE EXPRESSION ON THE OOCYTES AND GRANULOSA CELLS OF EARLY PREANTRAL FOLLICLES.
S.-Y. Ku, H.-C. Liu, W. Wang, Z. He, M. Jung, Z. Rosenwaks.
4:45 pm O-189 WITHDRAWN
Members Meetings
5:00 pm-5:30 pm
-
Contraception Special Interest Group
Room: 201 -
Genetic Counseling Special Interest Group
Room: 148 -
Pediatric and Adolescent Gynecology Special Interest Group
Room: 153 -
Reproductive Immunology Special Interest Group
Room: 159AB -
Sexuality Special Interest Group
Room: 143C -
Endometriosis Special Interest Group
Room: 204BC -
Middle East Fertility Society
Room: 151A -
Legal Professional Group
Room: 208A -
Fibroids Group
Room: 204A
Poster Session
Wine & Cheese Reception
Location: Hall E
ASRM invites you to meet the poster presenters Monday and Tuesday evenings from 5:30 pm-7:00 pm and enjoy a sampling of delicious wines and cheeses. Authors of posters P-1 through P-448 will be present Monday evening; authors of posters P-449 through P-886 will be
present Tuesday evening.
Supported by Organon USA Inc.
Please note that on Monday, posters will be open from noon until 7:00 pm. On Tuesday, posters will open at 9:30 am and close at 7:00 pm. On Wednesday, posters will open at 9:30 am and will conclude at 12:00 pm. ASRM cannot be responsible for removing and/or returning posters. All posters not removed will be discarded.
Go back to Monday's Overview | Go to Wednesday's Overview
By accessing and using the
ASRM Web Site, you agree to be bound by
the
ASRM Web Site Terms and Conditions of Use.
View the ASRM
Non Discrimination Policy
Copyright 1996-2008 ASRM, All Rights Reserved
American Society for Reproductive Medicine
Listed on Infertility
Resources
Developed and hosted by Internet
Health Resources